Brief: Galenica Sales Up 5.7% To CHF 3.17 Bln In First Nine Months Of 2026, Confirms Outlook
22/10/2026 05:45
BRIEF-Galenica Sales Up 5.7% To CHF 3.17 Bln In First Nine Months Of 2026, Confirms Outlook Oct 22 (Reuters) - Galenica AG GALE.S:
GALENICA CONTINUES GROWTH TRAJECTORY AND CONFIRMS OUTLOOK FOR 2026
GALENICA AG - SALES UP 5.7% TO CHF 3.17 BILLION IN FIRST NINE MONTHS OF 2026
GALENICA AG - PHARMACIES OMNI-CHANNEL NET SALES UP 6.2% TO CHF 1.13 BILLION, ORGANIC GROWTH 4.5%
GALENICA AG - PRODUCTS & BRANDS NET SALES CHF 136.50 MILLION, DOWN 7.2%
GALENICA AG - SERVICES & PRODUCTION NET SALES UP 5.8% TO CHF 93.60 MILLION IN FIRST NINE MONTHS OF 2026
Source text: ID:nEQ5p4x9Ja
Further company coverage: GALE.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Galenica AG
See all newsBrief: Galenica Successfully Places A Bond Of Over CHF 200 Million
Swiss stocks - Factors to watch on October 22
Brief: Galenica Sales Up 5.7% To CHF 3.17 Bln In First Nine Months Of 2026, Confirms Outlook
Swiss stocks - Factors to watch on September 2
Switzerland's Galenica H1 sales rise on pharmacy services demand